JPMorgan Chase & Co’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-721
Closed -$116 6688
2024
Q4
$116 Hold
721
﹤0.01% 5935
2024
Q3
$167 Hold
721
﹤0.01% 5855
2024
Q2
$392 Hold
721
﹤0.01% 5686
2024
Q1
$735 Hold
721
﹤0.01% 5660
2023
Q4
$411 Hold
721
﹤0.01% 5915
2023
Q3
$750 Hold
721
﹤0.01% 5718
2023
Q2
$1.02K Hold
721
﹤0.01% 5546
2023
Q1
$1K Hold
721
﹤0.01% 5697
2022
Q4
$1K Sell
721
-1,523
-68% -$2.11K ﹤0.01% 5502
2022
Q3
$10K Buy
2,244
+715
+47% +$3.19K ﹤0.01% 5075
2022
Q2
$6K Sell
1,529
-19,912
-93% -$78.1K ﹤0.01% 5276
2022
Q1
$102K Buy
21,441
+4,210
+24% +$20K ﹤0.01% 4739
2021
Q4
$63K Sell
17,231
-560,446
-97% -$2.05M ﹤0.01% 4995
2021
Q3
$4.63M Buy
577,677
+563,758
+4,050% +$4.52M ﹤0.01% 2630
2021
Q2
$158K Buy
+13,919
New +$158K ﹤0.01% 4593
2020
Q3
Sell
-1,003
Closed -$9K 5063
2020
Q2
$9K Buy
+1,003
New +$9K ﹤0.01% 4523
2018
Q4
Sell
-1,413
Closed -$99K 5004
2018
Q3
$99K Sell
1,413
-798
-36% -$55.9K ﹤0.01% 4126
2018
Q2
$164K Buy
2,211
+2,124
+2,441% +$158K ﹤0.01% 3908
2018
Q1
$8K Sell
87
-554
-86% -$50.9K ﹤0.01% 4529
2017
Q4
$83K Buy
641
+306
+91% +$39.6K ﹤0.01% 3966
2017
Q3
$22K Buy
+335
New +$22K ﹤0.01% 3958
2017
Q1
Sell
-121
Closed -$15K 4559
2016
Q4
$15K Buy
121
+69
+133% +$8.55K ﹤0.01% 4207
2016
Q3
$8K Sell
52
-163
-76% -$25.1K ﹤0.01% 3881
2016
Q2
$25K Hold
215
﹤0.01% 3672
2016
Q1
$24K Buy
215
+15
+8% +$1.67K ﹤0.01% 3568
2015
Q4
$38K Buy
200
+90
+82% +$17.1K ﹤0.01% 3414
2015
Q3
$19K Sell
110
-367
-77% -$63.4K ﹤0.01% 3270
2015
Q2
$301K Buy
477
+301
+171% +$190K ﹤0.01% 3214
2015
Q1
$91K Buy
176
+85
+93% +$43.9K ﹤0.01% 3388
2014
Q4
$49K Buy
+91
New +$49K ﹤0.01% 3351
2014
Q3
Hold
0
3513